Several brokerages have updated their recommendations and price targets on shares of DENTSPLY SIRONA (NASDAQ: XRAY) in the last few weeks:
- 11/16/2026 – DENTSPLY SIRONA had its price target lowered by UBS Group from $17.00 to $13.00. They now have a “buy” rating on the stock.
- 11/9/2026 – DENTSPLY SIRONA was downgraded by Zacks Research from “hold” to “strong sell”.
- 11/6/2026 – DENTSPLY SIRONA had its “buy” rating reaffirmed by Bank of America.
- 11/6/2026 – DENTSPLY SIRONA had its price target lowered by JPMorgan Chase & Co. from $12.00 to $10.00. They now have a “neutral” rating on the stock.
- 10/30/2026 – DENTSPLY SIRONA had its “sell (e+)” rating reaffirmed by Weiss Ratings.
- 10/26/2026 – DENTSPLY SIRONA had its price target lowered by Barrington Research from $15.00 to $13.00. They now have an “outperform” rating on the stock.
- 10/22/2026 – DENTSPLY SIRONA had its price target lowered by Mizuho from $14.00 to $12.00. They now have a “neutral” rating on the stock.
- 10/14/2026 – DENTSPLY SIRONA had its price target lowered by Leerink Partners from $14.00 to $10.00. They now have a “market perform” rating on the stock.
- 10/9/2026 – DENTSPLY SIRONA had its price target lowered by Piper Sandler from $14.00 to $12.00. They now have a “neutral” rating on the stock.
DENTSPLY SIRONA Stock Performance
NASDAQ:XRAY opened at $8.49 on Friday. DENTSPLY SIRONA Inc. has a 1 year low of $8.14 and a 1 year high of $14.76. The firm’s fifty day simple moving average is $9.25 and its 200 day simple moving average is $11.12. The company has a current ratio of 1.63, a quick ratio of 1.04 and a debt-to-equity ratio of 1.47. The firm has a market capitalization of $1.68 billion, a PE ratio of -13.69, a PEG ratio of 1.25 and a beta of 0.87.
DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last announced its earnings results on Thursday, November 5th. The medical instruments supplier reported $0.29 EPS for the quarter, missing the consensus estimate of $0.31 by ($0.02). The firm had revenue of $836.00 million during the quarter, compared to the consensus estimate of $861.68 million. DENTSPLY SIRONA had a positive return on equity of 20.21% and a negative net margin of 3.38%. The business’s revenue was down 7.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.37 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.200-1.300 EPS. On average, sell-side analysts anticipate that DENTSPLY SIRONA Inc. will post 1.21 EPS for the current year.
Read More
- Five stocks we like better than DENTSPLY SIRONA
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.
